Lithium Citrate Syrup and Ranibizumab ophthalmic
Determining the interaction of Lithium Citrate Syrup and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Citrate Syrup-Ranitidine
- Lithium Citrate Syrup-Ranitidine Capsule
- Lithium Citrate Syrup-Ranitidine Hydrochloride
- Lithium Citrate Syrup-Ranitidine Injection
- Lithium Citrate Syrup-Ranitidine Suspension
- Lithium Citrate Syrup-Ranitidine Syrup
- Ranibizumab ophthalmic-Lithium Controlled-Release and Extended-Release Tablets
- Ranibizumab ophthalmic-Lithium ER
- Ranibizumab ophthalmic-Lithium Oral Solution
- Ranibizumab ophthalmic-Lithium Salts
- Ranibizumab ophthalmic-Lithium Syrup and Oral Solution
- Ranibizumab ophthalmic-Lithobid